The multiplicative model for cancer risk assessment: Applicability to acrylamide

Carcinogenesis

Volumn 22, Issue 5, 2001, Pages 817-819

  Paulsson, B ^a   Granath, F ^b   Grawe J ^a   Ehrenberg, L ^a   Tornqvist M ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; ACRYLAMIDE DERIVATIVE; DNA; GLYCIDAMIDE; HEMOGLOBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY SURFACE; CANCER INCIDENCE; CANCER RISK; CANCER TEST; CARCINOGENICITY; CHEMICAL STRUCTURE; CHEMOSENSITIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; ENVIRONMENTAL PROTECTION; EVALUATION; EXPOSURE; GENOTOXICITY; IN VIVO STUDY; MALE; MATHEMATICAL MODEL; MEASUREMENT; METABOLISM; METABOLITE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; RODENT; SPECIES; UNITED STATES;

EID: 0035030890     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.5.817     Document Type: Article

References (14)

1. IARC (1994) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 60, Acrylamide. IARC, Lyon, pp. 389-433.
2. Calleman, C.J. (1996) The metabolism and pharmacokinetics of acrylamide: implications for mechanisms of toxicity and human risk. Drug Metab. Rev., 28, 527-590.
3. Sumner, S.C.J., Selvaraj, L., Nauhaus, S.K. and Fennell, T.R. (1997) Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days. Chem. Res. Toxicol., 10, 1152-1160.
4. Sumner, S.C.J., Fennell, T.R., Moore, T.A., Chanas, B., Gonzalez, F. and Ghanayem, B.I. (1999) Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem. Res. Toxicol., 12, 1110-1116.
5. 14C]acrylamide. Carcinogenesis, 16, 1161-1165.
6. Törnqvist, M., Bergmark, E., Ehrenberg, L. and Granath, F. (1998) Risk Assessment of Acrylamide, Report PM 7-98. National Chemicals Inspectorate, Solna, Sweden (in Swedish).
7. Granath, F., Vaca, C., Ehrenberg, L. and Törnqvist, M. (1998) Cancer risk estimation of genotoxic chemicals based on target dose and a multiplicative model. Risk Anal., 19, 319.
8. Ehrenberg, L., Moustacchi, S., Osterman-Golkar, S. and Ekman, G. (1983) Dosimetry of genotoxic agents and dose-response relationships of their effects. Mutat. Res., 123, 121-182.
9. Törnqvist, M., Mowrer, J., Jensen, S. and Ehrenberg, L. (1986) Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal. Biochem., 154, 255-266.
10. Miller, M.J., Carter, D.E. and Sipes, I.G. (1982) Pharmacokinetics of acrylamide in Fisher-334 rats. Toxicol. Appl. Pharmacol., 63, 36-44.
11. US EPA (1990) Assessment of Health Risks from Exposure to Acrylamide. US Environmental Protection Agency, Washington, DC.
12. Henderson, R.F., Thomton-Manning, J.R., Bechtold, W.E. and Dahl, A.R. (1996) Metabolism of 1,3-butadiene: species differences. Toxicology, 113, 17-22.
13. US EPA (1996) Proposed guidelines for carcinogen risk assessment. Fed. Regist., 61, 17960-18011.
14. The National Research Council's Committee on the Biological Effects of Ionizing Radiations (BEIR) (1990) Health Effects of Exposure to Low Levels of Ionizing Radiation, BEIR V. National Academic Press, Washington, DC, pp. 161-241.